Elapegademase
id:
elapegademase-262-17318555
title:
Elapegademase
text:
Elapegademase, sold under the brand name Revcovi, is a medication for the treatment of the rare disease adenosine deaminase deficiency-SCID in children and adults. It is a recombinant enzyme that is administered weekly by intramuscular injection. Elapegademase may interact with PEGylated drugs. Elapegademase-lvlr was approved by the U.S. Food and Drug Administration (FDA) in 2018. Leadiant Biosciences was awarded a priority review voucher for its development under the pediatric rare diseases pro
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Elapegademase
date created:
date modified:
2022-05-30T06:17:07Z
main entity:
{"identifier":"Q65087024","url":"https://www.wikidata.org/entity/Q65087024"}
image:
fields total:
13
integrity:
13